Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/15/2000CA2354040A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
06/15/2000CA2354035A1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis
06/15/2000CA2354022A1 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase
06/15/2000CA2354021A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative
06/15/2000CA2353867A1 Anticancer agents based on prevention of protein prenylation
06/15/2000CA2353839A1 Methotrexate derivatives
06/15/2000CA2353809A1 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
06/15/2000CA2353721A1 Deodorant cosmetic composition
06/15/2000CA2353620A1 Methods and formulations for reducing circulating antibodies
06/15/2000CA2353618A1 Benzofuran derivatives, their preparation and use
06/15/2000CA2353616A1 Assays for compounds which increase phospholipase a2 activity
06/15/2000CA2353525A1 Drug targets in candida albicans
06/15/2000CA2353516A1 Cancer treatment composition and method using natural plant essential oils
06/15/2000CA2353476A1 Cancer treatment composition and method using signal transduction modulators and natural plant essential oils
06/15/2000CA2353475A1 Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
06/15/2000CA2353462A1 Molecular scaffolds acting as templates comprising carbamate linkages
06/15/2000CA2353415A1 Vitronectin receptor antagonist
06/15/2000CA2352758A1 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same
06/15/2000CA2352250A1 Apparatus for separating particles of cohesive material according to size and process
06/15/2000CA2352178A1 Phospholipid compositions
06/15/2000CA2351690A1 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
06/15/2000CA2351452A1 Methods and compositions useful for targeting activated vitronectin receptor .alpha.v.beta.3
06/15/2000CA2351403A1 Thiourea inhibitors of herpes viruses
06/15/2000CA2351390A1 Thiourea inhibitors of herpes viruses
06/15/2000CA2351060A1 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/15/2000CA2351059A1 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/15/2000CA2350996A1 Thiourea inhibitors of herpes viruses
06/15/2000CA2350899A1 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
06/15/2000CA2350888A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction
06/15/2000CA2350887A1 Non-peptide antagonists of glp-1 receptor and methods of use
06/15/2000CA2350833A1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
06/15/2000CA2350767A1 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
06/15/2000CA2350590A1 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
06/15/2000CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000CA2326842A1 Micronized eplerenone compositions
06/15/2000CA2319561A1 Peritoneal dialysis solution containing modified icodextrins
06/15/2000CA2319435A1 Triazolo derivatives and chemokine inhibitors containing the same as effective component
06/15/2000CA2317025A1 Pyridyl-bridgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors
06/14/2000EP1008594A1 Compounds derived from thophene and benzothiophene, and related utilisation and composition
06/14/2000EP1008588A1 11,15-o-dialkylprostaglandin e derivatives, process for producing the same, and drugs containing the same as the active ingredient
06/14/2000EP1008349A1 Neovascularization promoters
06/14/2000EP1008348A1 Thrombolytic agent
06/14/2000EP1008347A1 Preventives or remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
06/14/2000EP1008346A1 NF-$g(k)B INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT PHENYLMETHYL BENZOQUINONE
06/14/2000EP1008345A1 Antiallergic agents
06/14/2000EP1008344A2 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
06/14/2000EP1008342A2 Pharmaceutically active compounds and liposomes, and methods of use thereof
06/14/2000EP1007735A1 Anti-sense oligonucleotide pharmacological agents
06/14/2000EP1007714A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
06/14/2000EP1007693A1 Pak kinase genes and polypeptides and methods of use thereof
06/14/2000EP1007691A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
06/14/2000EP1007687A1 Fiv vaccine
06/14/2000EP1007679A1 Recombinant human erythropoietin with advantageous glycosylation profile
06/14/2000EP1007677A2 Protease-related protein
06/14/2000EP1007673A1 Novel bone mineralization proteins, dna, vectors, expression systems
06/14/2000EP1007672A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
06/14/2000EP1007658A2 Mdm2-specific antisense oligonucleotides
06/14/2000EP1007657A2 Hiv-specific oligonucleotides and methods of their use
06/14/2000EP1007656A1 Modified protein kinase a-specific oligonucleotides and methods of their use
06/14/2000EP1007655A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
06/14/2000EP1007650A1 Pca3, pca3 genes, and methods of use
06/14/2000EP1007632A1 Isolation of bone and cartilage precursor cells
06/14/2000EP1007566A2 Therapeutic use of the smr1 protein and active derivatives thereof
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
06/14/2000EP1007556A2 Troponin subunits and fragments useful as angiogenesis inhibitors
06/14/2000EP1007555A1 Tropoelastin derivatives
06/14/2000EP1007537A1 Receptor protein designated 2f1
06/14/2000EP1007535A1 Methods and compositions for diagnosis and treatment of breast cancer
06/14/2000EP1007534A1 Bh3 interacting domain death agonist
06/14/2000EP1007533A1 Bioconjugates and delivery of bioactive agents
06/14/2000EP1007528A2 Robustaflavone, intermediates and analogues and method for preparation thereof
06/14/2000EP1007527A1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
06/14/2000EP1007526A1 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
06/14/2000EP1007525A1 Aminometyl oxooxazolidinyl benzene derivatives
06/14/2000EP1007524A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
06/14/2000EP1007523A1 Indole and 2,3-dihydroindole derivatives, their preparation and use
06/14/2000EP1007522A1 2- 4-[4-(4, 5-dichloro -2-methylimidazol-1-yl) butyl]-1-piperazinyl -5-fluoropyrimidine,preparation and therapeutic use
06/14/2000EP1007521A1 Compounds possessing neuronal activity
06/14/2000EP1007520A1 2-aminopyridines containing fused ring substituents as nos inhibitors
06/14/2000EP1007519A1 Treatment for cancer and compounds for use therewith
06/14/2000EP1007518A1 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
06/14/2000EP1007516A1 Dicyclanil polymorphs and hydrates and their preparation
06/14/2000EP1007514A1 Heterocyclic ketones as npy y5 antagonists
06/14/2000EP1007512A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
06/14/2000EP1007509A2 Antimicrobial compounds
06/14/2000EP1007505A1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
06/14/2000EP1007504A1 Sterilized 5-aminolevulinic acid
06/14/2000EP1007101A2 Improvements in or relating to diagnostic/therapeutic agents
06/14/2000EP1007098A2 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
06/14/2000EP1007096A1 Arginine silicate inositol complex and use thereof
06/14/2000EP1007095A2 Chimeric toxins for targeted therapy
06/14/2000EP1007094A1 Pharmaceutical compositions for freeze drying
06/14/2000EP1007089A1 Anticoagulant agents useful in treatment of thrombosis
06/14/2000EP1007086A1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection
06/14/2000EP1007079A1 Identification of broadly reactive dr restricted epitopes
06/14/2000EP1007077A1 Compounds and their combinations for the treatment of influenza infection
06/14/2000EP1007074A1 Hypothalamus-specific polypeptides
06/14/2000EP1007072A1 Glial cell line-derived neurotrophic factor receptors
06/14/2000EP1007068A1 Process for preparing synthetic soil-extract materials and medicaments based thereon
1 ... 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 6320 ... 7860